Britannia Pharmaceuticals Ltd is a UK-based pharmaceutical company focusing on the neurology market. As part of the STADA Arzneimittel AG group, the company specializes in innovative products for chronic and serious medical conditions, with a particular emphasis on Parkinson’s disease treatment.
The company, founded in 1981, is dedicated to improving the quality of life for people with Parkinson's disease. Its commitment is reflected in its slogan, "Caring for People's Health as a Trusted Partner."
Britannia Pharmaceuticals Ltd encourages prospective employees to explore current vacancies on their website. Additionally, the company emphasizes the importance of reporting adverse events, providing resources and contact information for this purpose.
Despite the lack of specific information on industries and headquarters, Britannia Pharmaceuticals Ltd's affiliation with the STADA Arzneimittel AG group enhances its credibility and market position. The company's focus on addressing significant medical needs holds promise for continued growth and development.
While no specific details of the last investment or the associated investors are available, Britannia Pharmaceuticals Ltd's dedication to neurological health and affiliation with a renowned pharmaceutical group position it favorably within the industry.
There is no investment information
No recent news or press coverage available for Britannia Pharmaceuticals Ltd.